•  
  •  
  •  
  •  

2025-10-06 17:58:01

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025

Keywords Selected:  INE298A01020

Stock Report

  • Cummins India Limited Commemorates 30 Years of Listing on NSE
  • Cummins India Ltd launches Battery Energy Storage Systems to power India's Clean Energy Transition
  • Cummins India unveils next-generation power solutions at baumaCONEXPO India 2024
  • Cummins India Ltd launches Retrofit Aftertreatment System, an innovative clean air solution for CPCBII and CPCBI gensets
  • Cummins India Ltd. and Sudhir Power Ltd. successfully concluded a mega roadshow in Rajasthan
  • Cummins India Ltd in collaboration with Repos Energy launches DATUM
  • Cummins India Ltd and Sudhir Power Ltd launch advanced CPCBIV+ compliant genset range in Delhi NCR
  • Cummins India Limited launches CPCBIV+ compliant power solutions
  • Cummins India Limited advances its mission of powering a more prosperous world, receives certification for CPCB IV+ emissions standard compliance
  • Cummins India Ltd recommends final dividend of Rs. 13
  • Cummins India Ltd declares interim dividend of Rs. 12
  • Cummins India Limited launches Retrofit Emission Control Device (RECD) for Cummins Genset Users
  • Cummins India Ltd recommends final dividend of Rs. 10.5
  • Cummins India Ltd Board declares Interim Dividend of Rs. 8
  • Cummins India Limited announces results for Q2 2021-22

Latest Post

  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024